中国网财经11月1日讯眼下当中国资产受到热捧时,医药行情始终保持着向上强攻的势头。在多重利好政策的作用下,艾美疫苗、荣昌生物、君实生物、药明生物等一众医药股一度均收获不俗涨幅,疫苗龙头艾美疫苗更是在本轮行情启动时,连续多个交易日领涨生物医药板块。 进入10月,艾美疫苗在研的重磅大单品疫苗频频传出利好消息。11月1日公司发布公告,公司自主研发的13价结合肺炎疫苗已向国家药品监督管理局提交药品上市...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.